• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,264.33 736.38
( 0.97%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
69,318.21 3,298.17
(5.00%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Alembic Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
533573
INE901L01018
285.6722314
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
APLLTD
21
14606.61
EPS(TTM)
Face Value()
Div & Yield %
35.39
2
1.61
 

MKVentures Capital reports consolidated net profit of Rs 0.47 crore in the March 2026 quarter
May 29,2026
Net profit of MKVentures Capital reported to Rs 0.47 crore in the quarter ended March 2026 as against net loss of Rs 5.30 crore during the previous quarter ended March 2025. Sales declined 77.49% to Rs 1.13 crore in the quarter ended March 2026 as against Rs 5.02 crore during the previous quarter ended March 2025.

For the full year,net profit rose 11.80% to Rs 10.61 crore in the year ended March 2026 as against Rs 9.49 crore during the previous year ended March 2025. Sales declined 60.70% to Rs 7.73 crore in the year ended March 2026 as against Rs 19.67 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1.135.02 -77 7.7319.67 -61
OPM %57.52-132.47 -175.0372.39 -
PBDT0.73-6.62 LP 13.4113.50 -1
PBT0.65-6.72 LP 13.1313.13 0
NP0.47-5.30 LP 10.619.49 12